The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study.
about
Methods to decrease blood loss and transfusion requirements for liver transplantationAnti-fibrinolytic use for minimising perioperative allogeneic blood transfusionMethods to decrease blood loss and transfusion requirements for liver transplantationThe pathophysiology of thrombocytopenia in chronic liver diseaseEffect of antifibrinolytic drugs on transfusion requirement and blood loss during orthotopic liver transplantation: Results from a single center.Antifibrinolytics in liver surgery.New insights into the coagulopathy of liver disease and liver transplantationRisk Factors Associated with Reoperation for Bleeding following Liver TransplantationComparison of aprotinin and tranexamic acid in adult scoliosis correction surgeryHow to limit allogenic blood transfusion in children.Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis.Requirements for transfusion and postoperative outcomes in orthotopic liver transplantation: a meta-analysis on aprotinin.Major liver resection, systemic fibrinolytic activity, and the impact of tranexamic acid.Optimizing cost-effectiveness in perioperative care for liver transplantation: a model for low- to medium-income countries.Liver transplantation in Indian Armed Forces-initial experienceBlood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation.Evaluation of cell salvage autotransfusion utility during liver transplantation.Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood transfusion"-free hepatectomy.Comparing early liver graft function from heart beating and living-donors: A pilot study aiming to identify new biomarkers of liver injury.Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.Coagulation Management During Liver Transplantation: Use of Fibrinogen Concentrate, Recombinant Activated Factor VII, Prothrombin Complex Concentrate, and Antifibrinolytics.
P2860
Q24234278-89395AD6-7976-4AE8-A09B-E23523019D66Q24235627-A8AAFDE1-94C6-4209-BB1C-33F85C562397Q24236276-D8C86927-7A1E-4A8F-A9C5-53424264B379Q26749277-DFD2CE03-733C-4537-80E9-F6B1E68D6A27Q33559980-D65FE411-FACC-42B2-8181-00CF42A15677Q33790811-56E64842-4AE1-4670-9576-E0F47A898D14Q33866656-0C79C417-65EF-42EF-8EA6-6D7EEA8B8906Q34645893-9978FD61-2DE3-4674-B9B4-DF6E0D09E30CQ36004416-25FC99F1-05EE-4C12-9CE9-BBE3BC3D206DQ36292194-1C48FD48-D9EC-4C66-A1E8-A3CCDB66FF72Q36709677-6B5CE4D9-FE10-436E-A2ED-C0B53E6B5CBDQ37103324-0D9DDB86-8A8B-4E37-B689-B0F6C5361DD3Q37484574-03F6B0CE-1C9E-4C14-B792-56950A9A3BBCQ37916431-3E4E3243-3434-43EA-9754-05464A6BA963Q41809856-DDFD7736-447F-496F-80F6-CA1E4BBD3FE4Q41938260-B126A991-C55C-48BB-90FF-31D5958F8AECQ42572007-411EF850-CAC7-4372-8E28-25396F86D4C5Q46908065-8889290C-47CF-428F-8807-4027D7357F09Q47340068-B634B833-FB37-49BB-B4EB-B1114743F7D8Q50738170-1E50E36C-6A7B-4928-B6B2-BC814B3CD84BQ52445950-6A72B1DC-D384-4636-936D-A3F5B6E4EFD0
P2860
The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The prophylactic use of tranex ...... antation: a comparative study.
@en
The prophylactic use of tranex ...... antation: a comparative study.
@nl
type
label
The prophylactic use of tranex ...... antation: a comparative study.
@en
The prophylactic use of tranex ...... antation: a comparative study.
@nl
prefLabel
The prophylactic use of tranex ...... antation: a comparative study.
@en
The prophylactic use of tranex ...... antation: a comparative study.
@nl
P2093
P2860
P356
P1476
The prophylactic use of tranex ...... antation: a comparative study.
@en
P2093
Antoni Rafecas
Antoni Sabaté
Antonia Dalmau
Carlos Bartolomé
Eduard Jaurrieta
Juan Figueras
Maylin Koo
P2860
P304
P356
10.1002/LT.20075
P577
2004-02-01T00:00:00Z